Immuneering Corporation has established a Pancreatic Cancer Advisory Board, consisting of prominent oncology researchers, to provide strategic guidance on its lead clinical program, IMM-1-104 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback